Valuation : Medpace Holdings, Inc.

Market Cap 16.28B 14B 13.21B 12.03B 22.49B 1,556B 22.7B 157B 60.54B 789B 61.12B 59.79B 2,507B P/E 2026 *
33.2x
P/E 2027 * 30.4x
Enterprise Value 15.47B 13.31B 12.56B 11.44B 21.38B 1,479B 21.58B 150B 57.55B 750B 58.11B 56.84B 2,384B EV / Sales 2026 *
5.43x
EV / Sales 2027 * 4.96x
Free-Float
80.34%
Yield 2026 *
-
Yield 2027 * -
1 day-0.54%
1 week-1.72%
Current month-1.82%
1 month-3.20%
3 months+25.21%
6 months+24.93%
Current year+3.83%
1 week 577.64
Extreme 577.64
596.98
1 month 571.01
Extreme 571.01
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 30/06/1992
Director of Finance/CFO 51 31/07/2021
Chief Tech/Sci/R&D Officer 65 31/08/2017
Director TitleAgeSince
Chairman 69 30/06/1992
Director/Board Member 55 30/06/2016
Director/Board Member 72 30/06/2016
Date Insider Type Main position Quantity % Market Cap. Importance
27/08/26 Sell

Chief Executive Officer

-650 0.0023%
26/08/26 Exercice

Director

11,574 0.0415%
26/08/26 Sell

Chief Executive Officer

-4,000 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%-1.72%+22.34%+115.10% 16.28B
+0.39%-5.32%-3.83%+10.22% 46.05B
-2.08%-3.57%+402.72%+533.09% 43.59B
+0.12%-5.27%+39.94%+20.50% 42.35B
-2.62%-5.76%+8.88%+77.44% 38.86B
-1.26%-3.37%+11.87%+40.55% 32.24B
+0.16%-3.65% - - 17.16B
+0.51%-1.95%+11.41%+31.60% 14.32B
-1.92%-6.94%+78.12%+36.68% 13.03B
+3.87%+1.29%+0.15%-33.76% 12.78B
Average -0.33%-4.10%+63.51%+92.38% 27.67B
Weighted average by Cap. -0.66%-4.75%+82.24%+120.47%

Financials

2026 *2027 *
Net sales 2.85B 2.45B 2.31B 2.11B 3.94B 273B 3.98B 27.56B 10.61B 138B 10.71B 10.47B 439B 3.03B 2.6B 2.46B 2.24B 4.18B 289B 4.22B 29.25B 11.26B 147B 11.37B 11.12B 466B
Net income 503M 432M 408M 371M 694M 48.05B 701M 4.86B 1.87B 24.37B 1.89B 1.85B 77.41B 547M 470M 444M 404M 755M 52.26B 762M 5.28B 2.03B 26.51B 2.05B 2.01B 84.19B
Net Debt -802M -690M -651M -593M -1.11B -76.7B -1.12B -7.75B -2.98B -38.91B -3.01B -2.95B -124B -1.25B -1.08B -1.02B -926M -1.73B -120B -1.75B -12.1B -4.66B -60.72B -4.7B -4.6B -193B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
10/09/26 US$583.16 -0.54% 195,558
09/09/26 US$586.30 -0.78% 206,891
08/09/26 US$590.89 -0.07% 185,218
04/09/26 US$591.29 -0.35% 146,430
03/09/26 US$593.39 +0.06% 143,232
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
583.16USD
Average target price
581.83USD
Spread / Average Target
-0.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!